|
|
40
|
|
|
59613
|
|
|
GALVUSMET 500MG | 50MG TAB (NVS/COL) METFORMIN | VIDAGLIPTIN
|
|
|
METFORMIN|VIDAGLIPTIN
|
|
|
GALVUSMET
|
|
|
56'S
|
|
|
B
|
|
|
32.62
|
|
|
0.58
|
|
|
500MG|50MG
|
|
|
TABLET
|
|
|
60
|
|
|
TAB
|
|
|
NVS
|
|
|
NOVARTIS CARIBE SA
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
B
|
|
|
Anti-Diabetic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
682005
|
|
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
|
|
|
Oral
|
|
|
6
|
|
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|